• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Naphthyridine carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Naphthyridines Naphthyridine carboxylic acids and derivatives

Recent Advances in the Study of 1,5-Naphthyridine-2-carboxylic Acid (CAS: 49850-62-6) in Chemical Biology and Pharmaceutical Research

1,5-Naphthyridine-2-carboxylic acid (CAS: 49850-62-6) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and drug discovery. This compound serves as a key scaffold for the development of novel therapeutic agents, particularly in the areas of oncology, infectious diseases, and inflammation. Recent studies have highlighted its potential as a pharmacophore in the design of kinase inhibitors, antimicrobial agents, and anti-inflammatory drugs. The unique structural features of 1,5-naphthyridine-2-carboxylic acid, including its ability to form hydrogen bonds and participate in π-π stacking interactions, make it an attractive candidate for targeting a wide range of biological macromolecules.

One of the most notable advancements in the study of 1,5-naphthyridine-2-carboxylic acid is its role in the development of kinase inhibitors. Kinases are critical regulators of cellular signaling pathways, and their dysregulation is often associated with cancer and other diseases. Recent research has demonstrated that derivatives of 1,5-naphthyridine-2-carboxylic acid exhibit potent inhibitory activity against various kinases, including EGFR, VEGFR, and CDK4/6. For instance, a study published in the Journal of Medicinal Chemistry (2023) reported the synthesis of a series of 1,5-naphthyridine-2-carboxylic acid derivatives that showed nanomolar potency against EGFR mutants resistant to first-generation inhibitors. These findings underscore the potential of this scaffold in overcoming drug resistance in cancer therapy.

In addition to its applications in oncology, 1,5-naphthyridine-2-carboxylic acid has also been explored as a building block for antimicrobial agents. The rise of multidrug-resistant pathogens has necessitated the discovery of new antibiotics with novel mechanisms of action. A recent study in Bioorganic & Medicinal Chemistry Letters (2023) described the synthesis of 1,5-naphthyridine-2-carboxylic acid derivatives with broad-spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. These compounds were found to inhibit bacterial DNA gyrase, a validated target for antibiotic development. The study also highlighted the favorable pharmacokinetic properties of these derivatives, suggesting their potential for further development as clinical candidates.

Another area of interest is the anti-inflammatory potential of 1,5-naphthyridine-2-carboxylic acid derivatives. Chronic inflammation is a hallmark of many diseases, including rheumatoid arthritis and inflammatory bowel disease. A recent publication in European Journal of Medicinal Chemistry (2023) reported the design and synthesis of novel 1,5-naphthyridine-2-carboxylic acid-based compounds that selectively inhibit the NLRP3 inflammasome, a key mediator of inflammatory responses. These compounds demonstrated significant efficacy in preclinical models of inflammation, with minimal off-target effects, highlighting their potential as next-generation anti-inflammatory agents.

The synthetic accessibility of 1,5-naphthyridine-2-carboxylic acid and its derivatives has also been a focus of recent research. Advances in catalytic methods, such as transition metal-catalyzed C-H activation and photoredox catalysis, have enabled the efficient and scalable synthesis of diverse 1,5-naphthyridine-2-carboxylic acid derivatives. A study in Organic Letters (2023) described a novel palladium-catalyzed annulation strategy for the rapid construction of 1,5-naphthyridine-2-carboxylic acid scaffolds with high regioselectivity and yield. These methodological innovations are expected to accelerate the exploration of this chemical space for drug discovery.

In conclusion, 1,5-naphthyridine-2-carboxylic acid (CAS: 49850-62-6) represents a promising scaffold in chemical biology and pharmaceutical research, with demonstrated applications in kinase inhibition, antimicrobial therapy, and anti-inflammatory drug development. The recent advancements in the synthesis and biological evaluation of its derivatives underscore its potential to address unmet medical needs. Future research should focus on optimizing the pharmacokinetic and pharmacodynamic properties of these compounds, as well as exploring their mechanisms of action in greater detail. The continued exploration of 1,5-naphthyridine-2-carboxylic acid and its derivatives is likely to yield novel therapeutic agents with significant clinical impact.

• 26469-60-3(Quinolinecarboxylic acid)
• 57709-61-2(H2phenda)
• 1211590-38-3(3H-Imidazo[4,5-c]pyridine-6-carboxylic acid)
• 24334-20-1(1H-pyrrolo2,3-cpyridine-2-carboxylic acid)
• 197507-59-8(1,6-Naphthyridine-2-carboxylic acid)
• 93-10-7(Quinoline-2-carboxylic acid)
• 1891-17-4(1,10-Phenanthroline-2-Carboxylic Acid)
• 17288-35-6(1H-Pyrrolo[3,2-b]pyridine-2-carboxylic acid)
• 130473-27-7(1H-Pyrrolo[2,3-c]pyridine-5-carboxylic acid)
• 872355-64-1(1H-Pyrrolo[3,2-b]pyridine-5-carboxylic acid)